New partnership combines AI-powered evidence synthesis with trusted pharmacist-led audio content to elevate clinical education as healthcare audiences shift toward credible, audio-first media ...
CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of ...
ValueDo Life Sciences Consulting, partner to over 20 global pharmaceutical companies across 25 markets, today announced the ...
CytoAgents, Inc. a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of ...
Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the pricing of an underwritten ...
Mr. Morris will lead efforts to expand manufacturing capacity and business developmentMINNEAPOLIS--(BUSINESS ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...
Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformationHer ...
The outpatient clinics market is projected to expand at a compound annual growth rate (CAGR) of 8% over the forecast period.
AUSTIN, TX / ACCESS Newswire / December 16, 2025 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare ...
Inclusion Among 18 Covered Products Makes Kerecis an Easy Partner for ProvidersARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--#kerecis--Kerecis, the company pioneering the use of sustainably ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback